Current understanding of the cardiomyopathies generally permits their recognition to be approached just as directly as other cardiac diagnoses. It begs the (luestion to say that certain alternatives must first be eliminated. Of course this is so. but such is the case with many diseases that are not merely diagnosed bv exclusion.
Primary myocardial disease is best understood within the framework of some type of orderly grouping. Accordingly, classification has been approached from tWo points of view: (1) pathophysiologic, i.e. how the myocardium is affected in terms of structural and functional derangement,' and (2) etiologic, i.e. the causes or presumed causes of the yvocardial abnormalities. Concomitant consideration of both of these issues puts us in position to deal more intelligently with the clinical manifestations, natural history, and management. These classifications are appropriate for 1971. Time will undoubtedly dictate changes.
Pathophysiologic Classification
The pathophvsiologic varieties of primary cardiomyopathy include the following alone or in combination: hypertrophic, hvperkinetic, obstructive, congestive, and restrictive. For practical purposes, left ventricular or biven-tricular involvement is, with rare exception, always present. Hypertrophic cardiomyopathy implies an increase in left ventricular free-wall thickness, which may initially express itself clinically as uncomplicated hypertrophy with little or no functional impairment. Hyperkinetic cardiomyopathy4 means that the left ventricle contracts at an inappropriately fast rate. When the left ventricle is both hypertrophic and hyperkinetic the stage is set for obstructive cardiomyopathy, which has also been designated idiopathic hypertrophic subaortic stenosis, or muscular subaortic stenosis. Recognition of primary myocardial disease is simplest when comparatively young, normotensive individuals present with cardiomegaly, left ventricular hypertrophy, tachyarrhythmias, conduction disturbances, or heart failure, without a prior cardiac history and without clinical evidence of acquired valvular heart disease, congenital heart disease, or disease of the coronary arteries, lungs, or pericardium. Such individuals initially may be asymptomatic. On the other hand, cardiac failure may be sudden and unremitting, or tachyarrhythmias dangerous and rapidly fatal before heart failure has had time to develop. More specific clinical manifestations are shown in table 2.
The uncomplicated pathophysiologic categories are often readily suspected in the context of the history, physical signs, electrocardiogram, and X-rays, but at other times characterization and differential diagnosis demand hemodynamic investigation. The distinction between hyperkinetic and hypertrophic cardiomyopathy with and without obstruction may require physical and pharmacologic interventions in the catheterization laboratory. Special concern attends the differential diagnosis between restrictive cardiomyopathy (a nonsurgical disease) and noncalcific constrictive pericarditis, which may be amendable to surgical relief. Although thoracotomy has often been preformed in order to Circulation, Volume XLIV, November 1971 94t6 make this distinction, coronary arteriography has recently been employed to define the ventricular epicardium and estimate the thickness of overlying pericardium. 6 In considering the pathophysiologic categories, we should understand that some patients with primary myocardial disease, especially those with asymptomatic idiopathic cardiomegaly, may have hearts that clinically function normally or nearly so. Furthermore, the basic pathophysiologic disturbance may, during its natural history, assume features of other categories: hyperkinetic hearts become hypertrophic, hypertrophic hearts fail, and restricted hearts produce circulatory congestion.
Once the presence and pathophysiologic type of primary myocardial disease have been satisfactorily established, we next turn attention to the etiologic categories themselves ( Pharmacologic management involves four considerations, namely: congestive heart failure; rate, rhythm, and conduction disturbances; thromboembolic complications; and antiinflammatory principles. The use of digitalis, diuretics, and sodium restriction is, as a rule, beneficial in treating the congestive heart failure of both acute and chronic cardiomyopathies. Concern with increased sensitivity to digitalis,25 especially in acute myocarditis, speaks for the use of rapidly acting, rapidly excreted preparations such as digoxin without loading doses and with comparatively small maintenance doses. Serious tachyarrhythmias and conduction disturbances should not simply be managed by standard pharmacologic regimens, but instead should be handled in intensive-care units until control has reduced the threat of sudden death. Anticoagulants should be used both for and in anticipation of pulmonary embolism (chronic congestive heart failure) and for systemic embolism from mural thrombi (especially during cardioversion). The management of contributory or aggravating causes in patients with primary myocardial disease has received considerable attention, and justifiably so. An increased burden on an already diseased heart is clearly undesirable. A number of factors are relevant in this regard, namely, exercise, obesity, environmental stress, heat and humidity, hypoxia, respiratory infections of bacterial etiology, coexisting systemic disease, and preexisting cardiovascular disease. Limitations of physical activity during the acute phase of myocarditis and in the presence of overt congestive heart failure seem to be appropriate based on simple hemodynamic considerations alone. In addition, exercise has been shown to increase myocardial proliferation of cardiotropic strains of Coxsackie virus in inoculated mice. Dr. George Burch has observed that otherwise intractable heart failure in chronic congestive cardiomyopathy may respond to prolonged bed rest.7 27 Care must be taken in assigning the degree and duration of physical limitations believed to be appropriate for a given patient. An asymptomatic individual with idiopathic cardiomegaly may require only moderate restriction. A class 4 patient with congestive cardiomyopathy may respond only to bed rest for a year or more. Prolonged bed rest, though widely applied, is still a debated issue. Furthermore, we lack precise information regarding the cardiocirculatory effects of protracted physical immobilization in normal man.
